Mij
Senior Member (Voting Rights)
Highlights
Fatigue is the most common symptom among multiple sclerosis (MS) patients and severely affects the quality of life. We investigate how perceived fatigue can be predicted using biomarkers collected from an arm-worn wearable sensor for MS patients (n = 51) and a healthy control group (n = 23) at an unprecedented time resolution of more than five times per day. On average, during our two-week study, participants reported their level of fatigue 51 times totaling more than 3,700 data points. Using interpretable generalized additive models, we find that increased physical activity, heart rate, sympathetic activity, and parasympathetic activity while awake and asleep relate to perceived fatigue throughout the day—partly affected by dysfunction of the ANS. We believe our analysis opens up new research opportunities for fine-grained modeling of perceived fatigue based on passively collected physiological signals using wearables—for MS patients and healthy controls alike.
VAS fatigue ratings among different subgroups
Between the control group and MS patients, we found differences in the distribution of VAS fatigue ratings. Table 1 displays average baseline characteristics of the healthy controls (Co), MS patients with a functional ANS (MS I) and MS patients with a dysfunctional ANS (MS II), and whether the differences are statistically significant. Table 1 shows that VAS fatigue ratings significantly differ between MS patients with a dysfunctional ANS and MS patients with a functional ANS (p = 0.026). The two groups also significantly differ in terms of EDSS and FSMC scores, as well as heart rate variability (HRV) metrics (Table S3 in the Appendix). FSMC scores also significantly differ between MS patients with a dysfunctional ANS and the control group but not MS patients with a functional ANS and the control group.
Concluding remarks
In this paper, we have highlighted that state fatigue can be modeled at a time resolution of multiple times a day for healthy individuals and MS patients alike. Based on passively collected data alone, our models clearly outperformed baseline regressors predicting each participant’s average response over our two-week study duration. Dysfunction of the ANS affects the relationship between biomarkers and state fatigue. For healthy individuals, MS patients with a functional ANS, and MS patients with a dysfunctional ANS, state fatigue thus has to be analyzed separately.
VAS fatigue ratings follow a daily upward trend and the time of day and the time participants spent awake were the strongest predictors for state fatigue. Deviations from this daily upward trend might be explained by changes in biomarkers related to cardiac, ANS, electrodermal, and physical activity. The calculated effects linked to the activity of the sympathetic nervous system indicate that emotional states, such as stressful or particularly calming experiences, might affect state fatigue. Further, we find changes in biosignals while asleep to predict state fatigue throughout the following day. This highlights that sleep behavior and its relation to state fatigue should be studied more closely for healthy individuals and MS patients alike.
LINK
- Digital biomarkers predict fatigue ratings continuously throughout the day
- Physical and ANS activity while awake and asleep relate to fatigue ratings
- Dysfunction of the ANS alters the effects of biomarkers on fatigue ratings
Fatigue is the most common symptom among multiple sclerosis (MS) patients and severely affects the quality of life. We investigate how perceived fatigue can be predicted using biomarkers collected from an arm-worn wearable sensor for MS patients (n = 51) and a healthy control group (n = 23) at an unprecedented time resolution of more than five times per day. On average, during our two-week study, participants reported their level of fatigue 51 times totaling more than 3,700 data points. Using interpretable generalized additive models, we find that increased physical activity, heart rate, sympathetic activity, and parasympathetic activity while awake and asleep relate to perceived fatigue throughout the day—partly affected by dysfunction of the ANS. We believe our analysis opens up new research opportunities for fine-grained modeling of perceived fatigue based on passively collected physiological signals using wearables—for MS patients and healthy controls alike.
VAS fatigue ratings among different subgroups
Between the control group and MS patients, we found differences in the distribution of VAS fatigue ratings. Table 1 displays average baseline characteristics of the healthy controls (Co), MS patients with a functional ANS (MS I) and MS patients with a dysfunctional ANS (MS II), and whether the differences are statistically significant. Table 1 shows that VAS fatigue ratings significantly differ between MS patients with a dysfunctional ANS and MS patients with a functional ANS (p = 0.026). The two groups also significantly differ in terms of EDSS and FSMC scores, as well as heart rate variability (HRV) metrics (Table S3 in the Appendix). FSMC scores also significantly differ between MS patients with a dysfunctional ANS and the control group but not MS patients with a functional ANS and the control group.
Concluding remarks
In this paper, we have highlighted that state fatigue can be modeled at a time resolution of multiple times a day for healthy individuals and MS patients alike. Based on passively collected data alone, our models clearly outperformed baseline regressors predicting each participant’s average response over our two-week study duration. Dysfunction of the ANS affects the relationship between biomarkers and state fatigue. For healthy individuals, MS patients with a functional ANS, and MS patients with a dysfunctional ANS, state fatigue thus has to be analyzed separately.
VAS fatigue ratings follow a daily upward trend and the time of day and the time participants spent awake were the strongest predictors for state fatigue. Deviations from this daily upward trend might be explained by changes in biomarkers related to cardiac, ANS, electrodermal, and physical activity. The calculated effects linked to the activity of the sympathetic nervous system indicate that emotional states, such as stressful or particularly calming experiences, might affect state fatigue. Further, we find changes in biosignals while asleep to predict state fatigue throughout the following day. This highlights that sleep behavior and its relation to state fatigue should be studied more closely for healthy individuals and MS patients alike.
LINK